In a post hoc analysis of SUPPRESS-AF (341 patients with persistent AF and left atrial low-voltage areas), adding LVA ablation to PVI lowered AF/AT recurrence without diabetes (35% vs 49%, P=0.018) but not with diabetes (48% vs 40%, P=0.290); interaction P=0.041.
Secondary analysisn = 341
Ozaki et al. Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial